Stay updated on Fremanezumab Subq for Migraine Preven Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.

Latest updates to the Fremanezumab Subq for Migraine Preven Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.6.6 to v3.7.0 on the page, signaling a newer version of the ClinicalTrials.gov page. This appears to reflect internal updates or maintenance rather than a substantive change to study details or publicly visible content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This appears to be a minor maintenance update to the page's revision history and does not alter core content like study details or eligibility.SummaryDifference0.0%

- Check22 days agoChange DetectedAn NIH funding attribution line '2015 ( U.S. NIH Grant/Contract )' has been added to the study's identifiers section. This addition records funding information for the study but does not change the study design, eligibility, or reported outcomes.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page revision tag was updated to v3.6.5, indicating a newer build of the page. This update likely represents minor maintenance or polish without altering study content.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page revision tag updated from v3.6.3 to v3.6.4, indicating a new internal revision of the page. This change does not alter the visible content or study details.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.6.3 is now displayed, replacing v3.6.2. This indicates a new release/build of the page rather than content changes.SummaryDifference0.0%

Stay in the know with updates to Fremanezumab Subq for Migraine Preven Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.